NASDAQ:BDTX

Black Diamond Therapeutics Stock Forecast

etoro logo Buy BDTX
*Your capital is at risk
$1.97
-0.120 (-5.74%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of BDTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BDTX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Black Diamond Therapeutics Inc. stock price fell more than -5.74% Friday closing at $1.97
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since May 22, 2026 Loss -13.60%

The Black Diamond Therapeutics Inc. stock price fell by -5.74% on the last day (Friday, 5th Jun 2026) from $2.09 to $1.97. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 8.16% from a day low at $1.96 to a day high of $2.12. The price has fallen in 8 of the last 10 days and is down by -44.51% for this period. Volume has increased on the last day by 375 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $1.98 million.

Given the current short-term trend, the stock is expected to rise 14.18% during the next 3 months and, with a 90% probability hold a price between $2.25 and $4.20 at the end of this 3-month period.

BDTX Signals & Forecast

There are few to no technical positive signals at the moment. The Black Diamond Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.15 and $2.72. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 20, 2026, and so far it has fallen -45.28%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Black Diamond Therapeutics Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.160 between high and low, or 8.16%. For the last week, the stock has had daily average volatility of 6.07%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BDTX) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Black Diamond Therapeutics Inc. to open at $2.02, and during the day (based on 14 day Average True Range), to move between $1.84 and $2.10, which gives a possible trading interval of +/-$0.253 (+/-13.74%) up or down from last closing price. If Black Diamond Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 13.74% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $2.18, some $0.210 (10.66%) from the current price of $1.97, our system finds the risk reward not very attractive.

Is Black Diamond Therapeutics Inc. stock A Buy?

The Black Diamond Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Black Diamond Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.482 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $2.02 ( 2.37%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BDTX Performance

Trading levels for BDTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.18 10.49%
R2 2.12 7.39%
R1 2.08 5.47%
Price 1.97
S1 1.96 -0.734%
S2 1.92 -2.65%
S3 1.86 -5.75%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.33 18.27%
R2 2.28 15.74%
R1 2.18 10.66%
Price 1.97
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Black Diamond Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Black Diamond Therapeutics Inc. is BDTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Black Diamond Therapeutics Inc. Stock?
The Black Diamond Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Black Diamond Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Black Diamond Therapeutics Inc. Stock?
Black Diamond Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Black Diamond Therapeutics Inc. Stock.

What's the current price of Black Diamond Therapeutics Inc. Stock?
As of the end of day on the Jun 05, 2026, the price of an Black Diamond Therapeutics Inc. (BDTX) share was $1.97.

What is the 52-week high and low for Black Diamond Therapeutics Inc. Stock?
The 52-week high for Black Diamond Therapeutics Inc. Stock is $4.94 and the 52-week low is $1.93.

What is the market capitalization of Black Diamond Therapeutics Inc. Stock?
As of the Jun 05, 2026, the market capitalization of Black Diamond Therapeutics Inc. is 112.884M.

When is the next earnings date for Black Diamond Therapeutics Inc.?
The upcoming earnings date for Black Diamond Therapeutics Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT BLACK DIAMOND THERAPEUTICS INC.
Black Diamond Therapeutics
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penet...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29
W
WCLD
$27.34
17.78% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE